Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Composition for treating inflammatory bowel disease

An inflammatory bowel disease and prescription technology, applied in the direction of drug combination, pharmaceutical formula, organic active ingredients, etc., can solve problems such as unsatisfactory effect and large side effects, and achieve the goal of prolonging human lifespan, improving therapeutic effect, and enhancing oxygen supply. Effect

Inactive Publication Date: 2016-03-23
何松庆
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory and have large side effects. Therefore, it is an urgent task for the medical community to study the etiology of inflammatory bowel disease, find the cause of the disease, and take corresponding treatment measures.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] 1. 0.5 grams of Ganoderma lucidum, 0.5 grams of threonine, 1.2 grams of glutamine, 50 mg of vitamin C, 4 mg of vitamin E, 0.1 mg of vitamin A, and 0.6 mg of β-carotene are made into chewing agents, 2 to 4 times a day.

[0027] 2. 0.25 grams of Ganoderma lucidum, 0.25 grams of threonine, 0.6 grams of glutamine, 25 mg of vitamin C, 2 mg of vitamin E, 0.05 mg of vitamin A, and 0.3 mg of β-carotene are made into chewing agents, 2 to 4 times a day.

[0028] 3. 0.5 grams of Ganoderma lucidum, 0.5 grams of threonine, 1.2 grams of glutamine, 50 mg of vitamin C, 4 mg of vitamin E, 0.1 mg of vitamin A, and 0.6 mg of β-carotene are made into medicines, 2 to 4 times a day.

[0029] 4. 0.25 grams of Ganoderma lucidum, 0.25 grams of threonine, 0.6 grams of glutamine, 25 mg of vitamin C, 2 mg of vitamin E, 0.05 mg of vitamin A, and 0.3 mg of β-carotene are made into medicines, 2 to 4 times a day.

[0030] 5. 5 grams of Ganoderma lucidum, 0.5 grams of threonine, 1.2 grams of glutamine,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition comprises ganoderma, threonine, glutamine, vitamin C, vitamin E, vitamin A and beta-carotene, wherein ganoderma has efficacies of strengthening blood supply and oxygen supply to the human body; threonine is a component of mucoprotein; glutamine is a main energy source of intestinal mucosa; vitamin C, vitamin E, vitamin A and beta-carotene have functions of inhibiting the activity of oxygen free radicals, scavenging the oxygen free radicals, and protecting human cells. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of eliminating inflammation, repairing intestinal tissues and building the normal intestinal surface mucous layer barrier for the human body, and is used for effectively treating the inflammatory bowel disease.

Description

technical field [0001] The invention relates to a combination formula of Chinese medicinal materials, amino acids and vitamins for treating inflammatory bowel disease, and belongs to the field of medicines. Background technique [0002] Inflammatory bowel disease (inflammatory bowel disease, IBD) is a disease whose etiology and pathogenesis have not yet been fully clarified. Because the cause of the disease and the pathogenesis have not been fully elucidated, people cannot fundamentally prevent or delay the progress of the disease. [0003] Medical immunology believes that the immune system has abnormal recognition and tolerance to antigens, that is, it produces an immune response to the abnormal recognition of normal intestinal microorganisms, causing the disease. Histology and embryology believe that the high permeability of the intestinal mucosa leads to a large number of intestinal antigens entering the intestinal wall tissue, triggering a long-term response of the immu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/074A61P1/00A61K31/198A61K31/375A61K31/355A61K31/07A61K31/015
CPCA61K31/015A61K31/07A61K31/198A61K31/355A61K31/375A61K36/074A61K2300/00
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com